ADVATE

antihemophilic factor VIII · Shire

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for ADVATE, covering 2008-04-22 to 2026-04-24. Get the full timeline:

Most recent: EMA Authorised: Advate (octocog alfa) — Takeda Manufacturing Austria AG